You are using an older browser version. Please use a supported version for the best MSN experience.

Distribution and supply chain issues likely with COVID-19 vaccine

Moderna Therapeutics is touting results from its first phase of testing for a coronavirus vaccine. But problems are likely to arise once a cure is developed. Politico's health care reporter Sarah Owermohle joins CBSN's Reena Ninan to explain how the Trump administration may have issues with distributing and developing a vaccine.

UP NEXT

UP NEXT

image beaconimage beaconimage beacon